touchPODCAST

The path from detection to personalized long-term care for Fabry disease

touchEXPERT OPINIONS for touchENDOCRINOLOGY

Listen to three leading Fabry disease experts discuss early diagnosis, organ monitoring, long-term individualized care and future directions.

The experts

• Prof. Aleš Linhart, Charles University and General University Hospital, Prague, Czech Republic
• Dr Eric Wallace, University of Alabama at Birmingham School of Medicine, Birmingham, AL, USA
• Prof. William Wilcox, Emory University School of Medicine, Atlanta, GA, USA

This touchPODCAST is for healthcare professionals outside of the UK only.

This activity is funded by an independent medical education grant from Amicus Therapeutics Inc. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: 

www.touchENDOCRINOLOGY.com 

 

The path from detection to personalized long-term care for Fabry disease

touchEXPERT OPINIONS for touchCARDIO

Listen to three leading Fabry disease experts discuss early diagnosis, organ monitoring, long-term individualized care and future directions.

The experts

• Prof. Aleš Linhart, Charles University and General University Hospital, Prague, Czech Republic
• Dr Eric Wallace, University of Alabama at Birmingham School of Medicine, Birmingham, AL, USA
• Prof. William Wilcox, Emory University School of Medicine, Atlanta, GA, USA

This touchPODCAST is for healthcare professionals outside of the UK only.

This activity is funded by an independent medical education grant from Amicus Therapeutics Inc. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: 

www.touchCARDIO.com 

The path from detection to personalized long-term care for Fabry disease

touchEXPERT OPINIONS for touchNEUROLOGY

Listen to three leading Fabry disease experts discuss early diagnosis, organ monitoring, long-term individualized care and future directions.

The experts

• Prof. Aleš Linhart, Charles University and General University Hospital, Prague, Czech Republic
• Dr Eric Wallace, University of Alabama at Birmingham School of Medicine, Birmingham, AL, USA
• Prof. William Wilcox, Emory University School of Medicine, Atlanta, GA, USA

This touchPODCAST is for healthcare professionals outside of the UK only.

This activity is funded by an independent medical education grant from Amicus Therapeutics Inc. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: 

www.touchNEUROLOGY.com

Demystifying virology: The link between the HIV life cycle and ART

touchEXPERT OPINIONS for touchINFECTIOUS DISEASES

Listen to leading experts describe the HIV life cycle, the rationale for multidrug antiretroviral therapy (ART) regimens, mechanisms of ART resistance and how to manage it in people living with HIV.

The experts

• Prof. Anne-Mieke Vandamme - Katholieke Universiteit Leuven, Belgium
• Prof. José Arribas - La Paz Hospital, Madrid, Spain
• Prof. Antonella Castagna - Vita-Salute San Raffaele University, Milan, Italy

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical education grant from Viiv Healthcare. This activity is provided by touchIME.

For further information visit our website: 

https://touchinfectiousdiseases.com/education/demystifying-virology-the-link-between-the-hiv-life-cycle-and-art/

 

Knowledge for nurses ADC updates in breast cancer

touchIN CONVERSATION for touchONCOLOGY

Listen to Ms Nikolina Dodlek, an oncology nurse from Croatia, in conversation with Professor Sherko Kümmel, a leading medical oncologist from Germany. They respond to questions submitted by the HCP audience and provide their expert insights on the use of HER2-directed antibody–drug conjugates (ADCs) in the treatment of patients with breast cancer.

This touchPODCAST is for HCPs outside of the UK only.

This activity is funded by an independent medical education grant from Daiichi Sankyo Europe GmbH and AstraZeneca. This activity is provided by touchIME. touchIME is an EBAC® accredited provider.

For further information visit our website: https://touchoncologyime.org/knowledge-for-nurses-adc-updates-in-breast-cancer

Maximizing the possibilities in the evolving treatment paradigm for R/R follicular lymphoma

touchPANEL DISCUSSION for touchONCOLOGY 

Listen to a panel of leading experts discuss the latest evidence and clinical implications of recently approved treatments for relapsed/refractory follicular lymphoma (R/R FL), the importance of shared decision-making in treatment selection in the era of BsAb and CAR T-cell therapies, and the key considerations for treatment sequencing. 

The experts

• Dr Matthew Lunning, University of Nebraska, Omaha, NE, USA,
• Professor Charalambos Andreadis, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA,
• Dr Tara Graff, Mission Cancer and Blood, Des Moines, IA, USA.

This touchPODCAST is for HCPs only. 

This activity is funded by an independent medical education grant from Bristol Myers Squibb and is jointly provided by USF Health and touchIME.

For further information visit: https://touchoncologyime.org/evolving-treatment-paradigm-relapsed-refractory-follicular-lymphoma 

Maximizing the possibilities in the evolving treatment paradigm for R/R follicular lymphoma

touchPANEL DISCUSSION for touchHAEMATOLOGY

Listen to a panel of leading experts discuss the latest evidence and clinical implications of recently approved treatments for relapsed/refractory follicular lymphoma (R/R FL), the importance of shared decision-making in treatment selection in the era of BsAb and CAR T-cell therapies, and the key considerations for treatment sequencing. 

The experts

• Dr Matthew Lunning, University of Nebraska, Omaha, NE, USA,
• Professor Charalambos Andreadis, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA,
• Dr Tara Graff, Mission Cancer and Blood, Des Moines, IA, USA.

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical education grant from Bristol Myers Squibb and is jointly provided by USF Health and touchIME.

For further information visit: https://touchhaematologyime.org/evolving-treatment-paradigm-relapsed-refractory-follicular-lymphoma

 

Decoding HER2 in NSCLC: Advances in biomarker testing and targeted therapies

touchIN CONVERSATION for touchRESPIRATORY

Listen to a medical oncologist and a pathologist as they discuss HER2 alterations in non-small cell lung cancer (NSCLC), including the different types of HER2 alterations, key considerations for HER2 testing and the latest data for HER2-targeting treatments. 

The experts

• Prof. Enriqueta Felip - Medical Oncologist, Vall d'Hebron University Hospital, Barcelona, Spain
• Prof. Keith Kerr - Aberdeen University Medical School and Aberdeen Royal Infirmary, Aberdeen, UK

This touchPODCAST is for HCPs outside of the UK only.

This activity is funded by an independent medical education grant from AstraZeneca, and is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.

For further information visit our website: 

https://touchrespiratoryime.org/her2_nsclc_testing_and_targeted_therapies/

Decoding HER2 in NSCLC: Advances in biomarker testing and targeted therapies

touchIN CONVERSATION for touchONCOLOGY

Listen to a medical oncologist and a pathologist as they discuss HER2 alterations in non-small cell lung cancer (NSCLC), including the different types of HER2 alterations, key considerations for HER2 testing and the latest data for HER2-targeting treatments. 

The experts

• Prof. Enriqueta Felip - Medical Oncologist, Vall d'Hebron University Hospital, Barcelona, Spain
• Prof. Keith Kerr - Aberdeen University Medical School and Aberdeen Royal Infirmary, Aberdeen, UK

This touchPODCAST is for HCPs outside of the UK only.

This activity is funded by an independent medical education grant from AstraZeneca, and is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.

For further information visit our website: 

https://touchoncologyime.org/her2_nsclc_testing_and_targeted_therapies/

 

Early diagnosis and treatment of NMOSD: Practical insights

touchIN CONVERSATION for touchNEUROLOGY - Early diagnosis and treatment of NMOSD: Practical insights

Listen to a neurologist and a neuro-ophthalmologist, both renowned experts in neuromyelitis optica spectrum disorder (NMOSD), answer questions from the ophthalmology and neurology communities on the management of NMOSD. They discuss presenting symptoms, differential diagnoses, management of acute attacks and long-term treatment.

The experts:

• Prof. John Chen - Mayo Clinic, Rochester, MN, USA
• Prof. Friedemann Paul - Charité - Universitätsmedizin Berlin, Campus Mitte, Germany

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical education grant from Horizon Therapeutics. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchneurologyime.org/nmosd_diagnosis_treatment
https://touchneurologyime.org/nmosd_diagnosis_treatment